These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24233388)

  • 1. Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia.
    Edwards F; Arkell P; Fong ; Roberts LM; Gendy D; Wong CS; Ngu JC; Tiong LL; Bibi FM; Lai LY; Ong TK; Abouyannis M
    J Thromb Thrombolysis; 2014; 38(2):226-34. PubMed ID: 24233388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
    Yasaka M; Minematsu K; Yamaguchi T
    Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical heart valves: a tertiary hospital-based study in Botswana.
    Botsile E; Mwita JC
    Cardiovasc J Afr; 2020; 31(4):185-189. PubMed ID: 32181794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal INR level for warfarin therapy after mechanical mitral valve replacement.
    Kamthornthanakarn I; Krittayaphong R
    BMC Cardiovasc Disord; 2019 Apr; 19(1):97. PubMed ID: 31023235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement.
    Yu HY; Liu CH; Chen YS; Wang SS; Chu SH; Lin FY
    J Formos Med Assoc; 2005 Apr; 104(4):236-43. PubMed ID: 15909060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
    Wallentin L; Yusuf S; Ezekowitz MD; Alings M; Flather M; Franzosi MG; Pais P; Dans A; Eikelboom J; Oldgren J; Pogue J; Reilly PA; Yang S; Connolly SJ;
    Lancet; 2010 Sep; 376(9745):975-83. PubMed ID: 20801496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.
    Inoue H; Okumura K; Atarashi H; Yamashita T; Origasa H; Kumagai N; Sakurai M; Kawamura Y; Kubota I; Matsumoto K; Kaneko Y; Ogawa S; Aizawa Y; Chinushi M; Kodama I; Watanabe E; Koretsune Y; Okuyama Y; Shimizu A; Igawa O; Bando S; Fukatani M; Saikawa T; Chishaki A;
    Circ J; 2013; 77(9):2264-70. PubMed ID: 23708863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
    Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
    JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
    Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
    Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.
    Poli D; Antonucci E; Pengo V; Migliaccio L; Testa S; Lodigiani C; Coffetti N; Facchinetti R; Serricchio G; Falco P; Mangione C; Masottini S; Ruocco L; De Caterina R; Palareti G;
    Int J Cardiol; 2018 Sep; 267():68-73. PubMed ID: 29957264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of warfarin dosage fluctuation with time in therapeutic range for bleeding or thromboembolism rate in Chinese patients.
    Yu HY; Tsai HE; Chen YS; Hung KY
    J Formos Med Assoc; 2019 Feb; 118(2):611-618. PubMed ID: 30126761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing effectiveness of two anticoagulation management models in a Malaysian tertiary hospital.
    Thanimalai S; Shafie AA; Hassali MA; Sinnadurai J
    Int J Clin Pharm; 2013 Oct; 35(5):736-43. PubMed ID: 23715759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.
    Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V
    J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.